Nghĩa của từ basal cell carcinoma bằng Tiếng Việt
Tế bào đáy
Đặt câu có từ "basal cell carcinoma"
1. Basal Cell Carcinoma Treatment and Diagnosis
2. Basal cell carcinoma Basal cell carcinoma (also called Basal cell skin cancer) is most common type of skin cancer
3. What increases my risk of basal cell Carcinoma?
4. Basal cell carcinoma can be pigmented or nonpigmented
5. What increases my risk of Basal cell carcinoma?
6. Basal cell Carcinoma (BCC) is a common skin cancer
7. Basal cell carcinoma (BCC) is a common skin cancer
8. Who gets basal cell carcinoma? Risk factors for Bcc include:
9. Radiotherapy for basal cell carcinoma of the medial Canthus region
10. Ablation requsives free margins of 1 centimeter (except in solid basal cell carcinoma).
11. Basal cell carcinoma diagnosis is a frequent and daily occurrence across the UK
12. The goal of treatment for Basal cell carcinoma is to remove the cancer completely
13. Basal cell Carcinoma and squamous cell Carcinoma are different forms of nonmelanoma skin cancer
14. Physical examination showed exophytic erythematous tumour simulating a basal cell carcinoma or an adnexal tumour.
15. Basal cell Carcinoma has an excellent survival rate – especially when the cancer is detected early
16. We describe a 24-year-old man with primary basal cell carcinoma of the Caruncle
17. Basal cell carcinoma (BCC) is a common, locally invasive, keratinocyte cancer (also known as nonmelanoma cancer)
18. Basal cell carcinoma (BCC) is a type of skin cancer that begins in the Basal cells
19. Basal cell carcinoma (Bcc) is a common, locally invasive, keratinocyte cancer (also known as nonmelanoma cancer)
20. Statistics show that: The earlier basal cell Carcinoma is diagnosed, the better the patient’s chance of survival.
21. Basal-cell carcinoma (Bcc), also known as basal-cell cancer, is the most common type of skin cancer
22. Treatment selection can also depend on whether this is a first-time or a recurring Basal cell carcinoma
23. Carcinoma is the most common type of cancer, which includes adenoCarcinoma, squamous cell Carcinoma, and basal cell Carcinoma
24. Abstract Sunburn is a major preventable risk associated with the development of malignant melanoma and basal cell carcinoma.
25. Basal-cell carcinoma (BCC), also known as Basal-cell cancer, is the most common type of skin cancer
26. Patients who have had basal cell Carcinoma once have an increased risk of developing a recurrent basal cell
27. Basal cell carcinoma begins in the Basal cells — a type of cell within the skin that produces new skin cells as old ones die off. Basal cell carcinoma often appears as a slightly transparent bump on the skin, though it can take other forms.
28. Basal cell carcinoma is a cancer that grows on parts of your skin that get a lot of sun
29. Basal cell carcinoma (Bcc) is the most common form of skin cancer and the most frequently occurring form of all cancers
30. Polarization and Distribution of Tumor-Associated Macrophages and COX-2 Expression in Basal Cell Carcinoma of the Ocular Adnexae Curr Eye Res
31. Adenoid cystic carcinoma/basal cell carcinoma is very rare and consists of basal cell nests of varying size that infiltrate the stroma
32. The present invention is related to a pulse photodynamic therapy (or pulse PDT) treatment of actinic keratosis (AK) or basal cell carcinoma (BCC).
33. Basal cell carcinoma (BCC) is the most common form of skin cancer and the most frequently occurring form of all cancers. In the U.S
34. Squamous cell Carcinoma is the second most common type of skin cancer in the United States, after basal cell Carcinoma, with about 700,000 diagnosed each year
35. Basal cell carcinoma (BCC) is a common, locally invasive, keratinocytic, or nonmelanoma skin cancer.It is also known as rodent ulcer and Basalioma.Patients with BCC often develop multiple primary tumours over time.
36. PDT can be used as treatment for basal cell carcinoma (BCC) or lung cancer; PDT can also be useful in removing traces of malignant tissue after surgical removal of large tumors.
37. Metvixia® (MAL) was recently authorized in France for the topical photodynamic therapy of actinic keratosis, superficial basal cell carcinoma (except for lesions on the face) and cutaneous squamous cell carcinoma in situ.
38. The malignant potential of Adenoid cystic carcinoma/basal cell carcinoma is uncertain because of the small number of reported cases and limited follow-up, but some cases are malignant with EPE and distant
39. ‘Exposure to inorganic arsenic has been linked to Arsenical keratoses, squamous cell carcinoma in situ of the skin, and basal cell carcinoma.’ ‘Chemical lead, 1% antimonial lead, and Arsenical lead are most commonly employed for this purpose.’
40. ‘Exposure to inorganic arsenic has been linked to Arsenical keratoses, squamous cell carcinoma in situ of the skin, and basal cell carcinoma.’ ‘Chemical lead, 1% antimonial lead, and Arsenical lead are most commonly employed for this purpose.’
41. These syndromes include Muir-Torre syndrome, associated with cystic sebaceomas, Cowden syndrome, associated with multiple tricholemmomas, Carney complex associated with multiple superficial angiomyxomas, Birt-Hogg-Dubé syndrome associated with multiple fibrofolliculomas, tuberous sclerosis associated with multiple facial angiofibromas and so-called Koenen tumors, patients with renal cell cancer associated with pilar leiomyomatosis and uterine leiomyomas, Gardner syndrome associated with Gardner fibromas and nevoid basal cell carcinoma associated with multiple basal cell carcinomas in young patients.